Locus Cell Co

Locus Cell Co Rule of 40

The Rule of 40 of Locus Cell Co (6891.TWO) as of Oct 18, 2026 is -6,241.48 %. In the previous year, Rule of 40 was -34,620.51 % — a change of -81.97% (higher).

Rule of 40

-6,241.48 %

YoY

-81.97%

Last updated:

Rule of 40 of Locus Cell Co is 2024 -6,241.48 % . Rule of 40 of Locus Cell Co was 2023 -34,620.51 % . It decreases by -81.97% higher compared to the previous year.

The Locus Cell Co Rule of 40 history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Rule of 40
Date
Rule of 40
Jan 1, 2023
-34,620.51 TWD
Jan 1, 2024
-6,241.48 TWD
The Locus Cell Co Rule of 40 history
YEARRule of 40YoY
-6,241.48 %-81.97%
-34,620.51 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Locus Cell Co Stock analysis

What does Locus Cell Co do? Locus Cell Co Ltd is a company based in Taipei, Taiwan, operating within the Health Care sector, specifically in the Life Sciences Tools & Services industry. The company has 32 employees and went public on April 28, 2022. Its primary business involves the entrusted development and manufacturing of cell therapy-related products. Locus Cell Co Ltd utilizes a pilot facility compliant with Pharmaceutical Inspection Convention and Pharmaceutical Inspection Co-operation Scheme (PIC/S) good manufacturing practices (GMP). The company provides services including process development and scale-up for cell therapy products, analytical method development and validation, clinical GMP manufacturing for trials, and stability testing. It is anticipated to offer services for various cell therapy applications, such as tissue engineering, CAR-T, induced pluripotent stem cells (iPSCs), and mesenchymal stem cells (MSCs). The company's website is http://www.locus-cell.com/. Locus Cell Co Ltd focuses on contract development and manufacturing organization (CDMO) services for cell therapy products, aiming to support the advancement of innovative therapies through its specialized GMP-compliant facility and technical expertise in cell therapy processes. Locus Cell Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Locus Cell Co stock

Rule of 40 of Locus Cell Co is -6,241.48 % in 2024.

On Eulerpool you can find the complete historical development of Rule of 40 Locus Cell Co since 2006 – with annual values, charts, and detailed analysis.

The Rule of 40 states that a company's revenue growth rate plus profit margin should exceed 40%. It is widely used to evaluate SaaS and high-growth companies.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Quality — Locus Cell Co

All Key Metrics — Locus Cell Co